EVI has issued a call for auditing services, dealine on or before 31 May 2014
- Calls & Grants
- International Relations
- Vaccines & Diseases
- About us
- News & Events
The European Vaccine Initiative (EVI) is leading European efforts to develop effective, accessible, and affordable vaccines against diseases of poverty. EVI’s vision is 'a world free of the intolerable burden of diseases of poverty within the coming decades'.
EVI is contributing to the global efforts to control these diseases in three main ways:
The EVI portfolio comprises four vaccine candidates under development, the coordination of five European Commission funded projects under the Sixth and Seventh Framework Programme, as well as one European and Developing Countries' Clinical Trials Partnership funded project.
EVI continues not only to have many successes in the clinical development of malaria vaccine candidates (its initial mandate as EMVI), but also in the coordination of projects funded by the European Commission (EC) and others. EVI is now embarking on vaccine candidates for other diseases of poverty in line with its wider mandate.